Customer Guest
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Login | Register
Login | Register|Forgot password?
Anuh Pharma Limited has informed the Exchange regarding Completion Of European Directorate For The Quality Of Medicines & Healthcare (EDQM) Audit And...more...
Completion of European Directorate for the Quality of Medicines & Healthcare (EDQM) Audit and our facilities were found compliant under the Auditmore...
Anuh Pharma Limited has informed the Exchange about Newspaper Publication regarding notice to shareholders for Special Window for transfer and demate...more...
Investor Presentation for Q3 FY 2025-26more...
Anuh Pharma Limited has informed the Exchange about Investor Presentationmore...
Anuh Pharma Limited has informed the Exchange about Copy of Newspaper Publication of the Un-Audited financial results for the Quarter ended ...more...
Completion of United States Food and Drug Administration (USFDA) Inspection with no Form 483 observations issued.more...
Anuh Pharma Limited has informed the Exchange regarding Completion of United States Food and Drug Administration (USFDA) inspection with no ...more...
Granting Authorization to Key Managerial Personnel for determination of materiality of events/ information under Regulation 30 (5) of SEBI (LODR) Reg...more...
Anuh Pharma Limited has informed the Exchange regarding Granting Authorization to Key Managerial Personnel for determination of materiality ...more...
The company reported standalone net profit of Rs 13.45 crore for the quarter ended December 31 2025 as compared to Rs 10.34 crore in the same period ...more...
Unaudited Financial Results for the quarter ended 31st December 2025more...
Anuh Pharma Limited has submitted to the Exchange the financial results for the period ended December 31 2025.more...
Anuh Pharma Limited has informed the Exchange regarding the approval of Un-audited Financial Results for the quarter ended December 31 2025 ...more...
Anuh Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 inter alia to consider and appro...more...
Anuh Pharma Limited has informed the Exchange about orders passed regarding Assessment Order received under Section 143(3) read with Section...more...
As of December 2025 71.82% is owned by Promoters and 28.18% by Public. Among Promoters holding Indian Promoters holds 71.80% and Foreign Promoters ho...more...
Anuh Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...
Compliance Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 31st December 2025...more...
Anuh Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015more...
BOARD MEETINGS Company Name : Supha Pharmachem Date : 30-03-2026